Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Keybanc Analyst Reiterates Bullish Stance on Schrodinger with Revised Price Target

Elaine Mendonca by Elaine Mendonca
February 29, 2024
in Breaking News
0
Technology Blockchain Markets and money
0
SHARES
9
VIEWS
Share on FacebookShare on Twitter

Keybanc analyst Scott Schoenhaus has reiterated his bullish stance on Schrodinger (NASDAQ: SDGR), maintaining an Overweight rating on the stock. However, he has revised his price target down from $38 to $33. This adjustment follows his initial target of $38 and indicates a shift in his perspective on the company’s value and future prospects.

SDGR Stock Price Plummets by 18.84% on February 29, 2024: Is a Turnaround on the Horizon?

On February 29, 2024, SDGR stock experienced a significant drop in its price, closing at $25.46, which was a decrease of $5.91 or 18.84% from the previous market close. This drop in price is quite substantial and may have been concerning for investors holding SDGR shares.

However, there was a slight uptick in the stock price during after-hours trading, with SDGR rising $0.14. While this increase is modest, it may provide some hope for investors looking for a potential turnaround in the stock’s performance.

Investors should exercise caution and conduct thorough research before making any investment decisions related to SDGR.

SDGR Stock Analysis: Revenue Growth Amidst Rising Losses and Declining EPS

On February 29, 2024, SDGR stock experienced mixed performances based on the financial data provided by CNN Money. The company’s total revenue for the past year was $180.96 million, which marked a 31.19% increase compared to the previous year. In the third quarter, total revenue was reported at $42.57 million, showing a 20.97% increase from the previous quarter.

However, the company’s net income paints a different picture. SDGR reported a net loss of $149.19 million for the past year, reflecting a 48.6% decrease compared to the previous year. In the third quarter, the net loss was even higher at $62.02 million, representing a significant 1549.84% decrease from the previous quarter.

Earnings per share (EPS) also took a hit for SDGR. The company reported an EPS of -$2.10 for the past year, which was a 47.39% decrease compared to the previous year. In the third quarter, the EPS was even lower at -$0.86, marking a substantial 1612.98% decrease from the previous quarter.

Overall, the financial data shows that SDGR has experienced growth in total revenue but has struggled with increasing losses and declining EPS. Investors may be concerned about the company’s ability to turn its revenue growth into profitability. It will be important for SDGR to address its financial challenges and demonstrate a path towards sustainable growth in order to regain investor confidence and drive stock performance in the future.

Tags: SDGR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Food Producers Stock Bull Market

The Rewarding Investment of McDonalds Stock A 20Year Success Story

Xenon Pharmaceuticals Reports Strong Financial Position and Promising Pipeline for Neurological Disorders

Aerospace and Defense Stock Market Today (1)

Sidus Space Announces Public Offering of Class A Common Stock

Recommended

Anticipating Navigator Holdings Quarterly Earnings Report Analysts Predict 030 EPS

2 years ago
Sandy Spring Stock

Sandy Spring Bancorp’s Final Chapter: A New Era Under Atlantic Union

3 months ago
Certara Stock

Certara Stock: Regulatory Milestone and Strong Fundamentals Fuel Recovery Hopes

6 months ago
Meta Stock

Meta Faces Mounting Pressure from Regulators and Strategic Shifts

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Tellurian Acquisition Finalized as Woodside Takes Control

Coherus BioSciences Forges Key Oncology Alliance with Janssen

TCG BDC Investors Await Key Financial Milestones

Navigating Change: Schnitzer Steel’s Digital and Structural Evolution

Akso Health Group Pivots to Oncology with Global Patient Initiative

Trending

Deluxe Stock
Analysis

Deluxe Stock Gains Momentum on Successful Fintech Transition

by Kennethcix
February 6, 2026
0

Deluxe Corporation is successfully shedding its legacy identity as a check-printing specialist. The company's strategic pivot toward...

Hydrofarm Holdings Inc Stock

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

February 6, 2026
Northeast Bancorp Stock

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

February 6, 2026
Vir Biotechnology Stock

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

February 6, 2026
Tellurian Stock

Tellurian Acquisition Finalized as Woodside Takes Control

February 6, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Deluxe Stock Gains Momentum on Successful Fintech Transition
  • Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches
  • Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com